Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    9677101 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed MK-2206 and AZD6244 in Patients With Advanced Colorectal Carcinoma
Condition: Colorectal Neoplasms
Intervention: Drug: MK-2206 + AZD6244
2 Completed BAY 43-9006 Plus Cetuximab to Treat Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Cetuximab;   Drug: BAY 43-9006

Indicates status has not been verified in more than two years